Matrix metalloproteinase 9 targeting peptides: Syntheses, 68Ga-labeling, and preliminary evaluation in a rat melanoma xenograft model

Bioconjugate Chemistry

Volumn 21, Issue 9, 2010, Pages 1612-1621

  Ujula, Tiina ^a   Huttunen, Merja ^b   Luoto, Pauliina ^a   Peräkylä, Hannu ^b   Simpura, Ilkka ^b   Wilson, Ian ^c   Bergman, Mathias ^b   Roivainen, Anne ^a,d  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b Karyon CTT Ltd   (Finland)

^c GE Healthcare Finland Oy   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; DERMATOLOGY; DIAGNOSIS; ONCOLOGY; PLASMA STABILITY; POSITRON EMISSION TOMOGRAPHY; RADIATION; RADIOACTIVITY; RATS; TUMORS;

BIOPANNING; EX-VIVO; IN-VIVO; LABELINGS; MATRIX METALLOPROTEINASE-9; MELANOMA XENOGRAFTS; PEPTIDE SYNTHESIS; TARGETING PEPTIDES; TOMOGRAPHY IMAGING; TUMOUR CELLS;

PEPTIDES;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ABI 433A; CYSTINE; GALLIUM 68; GELATINASE B; LACTAM; PEPTIDE DERIVATIVE; TUMOR CELL TARGETING PEPTIDE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG BLOOD LEVEL; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TUMOR LEVEL; DRUG URINE LEVEL; MELANOMA; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; RAT; TUMOR XENOGRAFT;

RATTUS;

EID: 77956644470     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc1000643     Document Type: Article

References (41)

1. Benbow, U. and Brinckerhoff, C. E. (1997) The AP-1 site and MMP gene regulation: what is the fuss about? Matrix. Biol. 15, 519-526
2. Vihinen, P., Ala-aho, R., and Kähäri, V. M. (2005) Matrix metalloproteinases as therapeutic targets in cancer Curr. Cancer Drug Targets 5, 203-220
3. Johansson, N., Ahonen, M., and Kähäri, V. M. (2000) Matrix metalloproteinases in tumor invasion Cell. Mol. Life Sci. 57, 5-15
4. Ståhle-Bäckdahl, M. and Parks, W. C. (1993) 92kD gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma Am. J. Pathol. 42, 995-1000
5. Bloomston, M., Zervos, E. E., and Rosemurgy, A. S. (2002) Matrix metalloproteinases and their role in pancreatic cancer: A review of preclinical studies and clinical trials Ann. Surg. Oncol. 9, 668-674
6. Sternlicht, M. D. and Werb, Z. (2001) How matrix metalloproteinases regulate cell behaviour Annu. Rev. Cell Dev. Biol. 17, 463-516
7. Phillips, P. G. and Birnby, L. M. (2004) Nitric oxide modulates caveolin-1 and matrix metalloproteinase-9 expression and distribution at the endothelial cell/tumour cell surface Am. J. Physiol. Lung Mol. Physiol. 286, 1055-1065
8. Del Bufalo, D., Trisciuoglio, D., Scarsella, M., D'Amati, G., Candiloro, A., Iervolino, A., Leonetti, C., and Zupi, G. (2004) Lonidamine causes inhibition of angiogenesis-related endothelial cell functions Neoplasia 6, 513-522
9. Wikström, S. A., Keski-Oja, J., and Alitalo, K. (2003) Matrix reloaded to circulation hits the tumor target Cancer Cell 3, 513-514
10. Hofman, U. B., Westphal, J. R., Waas, E. T., Becker, J. C., Ruiter, D. J., and Van Muijen, G. N. (2000) Coexpression of integrin alpha(v)beta(3) and matrix metalloproteinase-2 (MMP2) coincides with MMP2 activation: correlation with melanoma progression J. Invest. Dermatol. 115, 625-632
11. Schnaeker, E. M., Ossig, R., Ludwig, T., Dreier, R., Oberleithner, H., Wilhelmi, M., and Schneider, S. W. (2004) Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion Cancer Res. 64, 8924-8931
12. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells Nature 370, 61-65
13. Brooks, P. C., Stromblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., and Cheresh, D. A. (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 Cell 85, 683-693
14. Deryugina, E. I., Ratnikov, B., Monosov, E., Postnova, T. I., DiScipio, R., Smith, J. W., and Strongin, A. Y. (2001) MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells Exp. Cell Res. 263, 209-223
15. Raithatha, S. A., Muzik, H., Rewcastle, N. B., Johnston, R. N., Edwards, D. R., and Forsyth, P. A. (2000) Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas Neuro-Oncology (Durham, NC, U. S.) 2, 145-150
16. Sakata, K., Satoh, M., Someya, M., Asanuma, H., Nagakura, H., Oouchi, A., Nakata, K., Kogawa, K., Koito, K., Hareyama, M., and Himi, T. (2004) Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma Cancer 100, 356-365
17. Spinale, F. G. (2002) Matrix metalloproteinases: regulation and dysregulation in the failing heart Circ. Res. 90, 520-530
18. Nikkola, J., Vihinen, P., Vuoristo, M. S., Kellokumpu-Lehtinen, P., Kähäri, V. M., and Pyrhönen, S. (2005) High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma Clin. Cancer Res. 11, 5158-5166
19. 11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents Nucl. Med. Biol. 29, 761-770
20. Robertson, L., Grip, L., Mattsson Hultén, L., Hulthe, J., and Wiklund, O. (2007) Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention J. Intern. Med. 262, 659-667
21. Whittager, M., Floyd, C. D., Brown, P., and Gearing, A. J. H. (1999) Design and therapeutic application of matrix metalloproteinase inhibitors Chem. Rev. 99, 2735-2776
22. Lim, G. P., Backstrom, J. R., Cullen, M. J., Miller, C. A., Atkinson, R. D., and Tökés, Z. A. (1996) Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients J. Neurochem. 67, 251-259
23. Lukes, A., Mun-Bryce, S., Lukes, M., and Rosenberg, G. A. (1999) Extracellular matrix degradation by metalloproteinases and central nervous system disease Mol. Neurobiol. 19, 267-284
24. Backstrom, J. R., Miller, C. A., and Tökés, Z. A. (1992) Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: identification of calcium-dependent metalloproteinases from the hippocampus J. Neurochem. 58, 983-992
25. Mun-Bryce, S., Lukes, A., Wallace, J., Lukes-Marx, M., and Rosenberg, G. A. (2002) Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation Brain Res. 933, 42-49
26. Segura-Valdez, L., Pardo, A., Gaxiola, M., Uhal, B. D., Becerril, C., and Selman, M. (2000) Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD Chest 117, 684-694
27. Smith, G. (1985) Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface Science 228, 1315-1317
28. Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O. P., Heikkilä, P., Kantor, C., Gahmberg, C. G., Salo, T., Konttinen, Y. T., Sorsa, T., Ruoslahti, E., and Pasqualini, R. (1999) Tumor targeting with a selective gelatinase inhibitor Nat. Biotechnol. 17, 768-774
29. Koivunen, E., Wang, B., Dickinson, C. D., and Ruoslahti, E. (1994) Peptides in cell adhesion research Methods Enzymol. 245, 346-369
30. Auvinen, M., Paasinen, A., Andersson, L. C., and Hölttä, E. (1992) Ornithine decarboxylase activity is critical for cell transformation Nature 360, 355-358
31. Auvinen, M., Laine, A., Paasinen-Sohns, A., Kangas, A., Kangas, L., Saksela, O., Andersson, L. C., and Hölttä, E. (1997) Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice Cancer Res. 57, 3016-3025
32. Welch, D. R., Bisi, J. E., Miller, B. E., Conaway, D., Seftor, E. A., Yohem, K. H., Gilmore, L. B., Seftor, R. E., Nakajima, M., and Hendrix, M. J. (1991) Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line Int. J. Cancer 47, 227-237
33. Peräkylä, H., Huttunen, M., Karisalmi, E. K., Bergman, M., and Elo, H. (2007) Peptide Conjugates, U.S. Patent App Pub US 0231258, WO/2007/113386.
34. Zheng, Q. H., Fei, X., Liu, X., Wang, J. Q., Stone, K. L., Martinez, T. D., Gay, D. J., Baity, W. L., Miller, K. D., Sledge, G. W., and Hutchins, G. D. (2004) Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4′-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4′-[11C]methoxyphenyl)sulfonyl]benzylamino]- 3-methylbutanamide Nucl. Med. Biol. 31, 77-85
35. Wagner, S., Breyholz, H. J., Höltke, C., Faust, A., Schober, O., Schäfers, M., and Kopka, K. (2009) A new 18F-labelled derivative of the MMP inhibitor CGS 27023A for PET: radiosynthesis and initial small-animal PET studies Appl. Radiat. Isot. 67, 606-610
36. Sprague, J. E., Li, W. P., Liang, K., Achilefu, S., and Anderson, C. J. (2006) In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models Nucl. Med. Biol. 33, 227-237
37. Hanaoka, H., Mukai, T., Habashita, S., Asano, D., Ogawa, K., Kuroda, Y., Akizawa, H., Iida, Y., Endo, K., Saga, T., and Saji, H. (2007) Chemical design of a radiolabeled gelatinase inhibitor peptide for the imaging of gelatinase activity in tumors Nucl. Med. Biol. 34, 503-510
38. Oltenfreiter, R., Staelens, L., Lejeune, A., Dumont, F., Frankenne, F., Foidart, J. M., and Slegers, G. (2004) New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents Nucl. Med. Biol. 31, 459-468
39. Kuhnast, B., Bodenstein, C., Haubner, R., Wester, H. J., Senekowitsch-Schmidtke, R., Schwaiger, M., and Weber, W. A. (2004) Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptide Nucl. Med. Biol. 31, 337-344
40. Medina, O. P., Kairemo, K., Valtanen, H., Kangasniemi, A., Kaukinen, S., Ahonen, I., Permi, P., Annila, A., Sneck, M., Holopainen, J. M., Karonen, S. L., Kinnunen, P. K., and Koivunen, E. (2005) Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide Anticancer Res. 25, 33-42
41. Koivistoinen, A., Taube, S., Huttunen, M., Sihvo, E., Peräkylä, H., Salo, J., and Bergman, M. G. (2006) Novel cancer targeting peptides for non-neuroendocrine tumour imaging Eur. J. Nucl. Med. Mol. Imaging 33, S265